Walvax Biotechnology Co., Ltd. (300142.SZ)
CNY 13.07
(0.31%)
CNY 13.07
(0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.11 Billion | 5.08 Billion | 3.46 Billion | 2.93 Billion | 1.12 Billion | 879.04 Million |
| Cost of Revenue | 683.76 Million | 609.46 Million | 394.33 Million | 399.8 Million | 227.09 Million | 172.34 Million |
| Gross Profit | 3.43 Billion | 4.47 Billion | 3.06 Billion | 2.53 Billion | 894.12 Million | 706.7 Million |
| Operating Expenses | 2.74 Billion | 3.14 Billion | 2.2 Billion | 1.51 Billion | 729.93 Million | 601.68 Million |
| Selling, General and Administrative Expenses | 1.83 Billion | 2.12 Billion | 1.49 Billion | 1.26 Billion | 619.11 Million | 403.54 Million |
| Research and Development Expenses | 776.42 Million | 932.89 Million | 621.49 Million | 176.49 Million | 64.81 Million | 125.48 Million |
| Other Expenses | 104.14 Million | 86.58 Million | 89.58 Million | 76.31 Million | 46.01 Million | -61.78 Million |
| Cost and Expenses | 3.49 Billion | 3.75 Billion | 2.59 Billion | 1.91 Billion | 957.03 Million | 774.02 Million |
| Operating Income | 613.96 Million | 1.09 Billion | 967.52 Million | 1.05 Billion | 232.88 Million | 1.24 Billion |
| Interest Expense | 4.15 Million | 7.1 Million | 5.77 Million | 597.48 Thousand | 30.56 Million | 39.79 Million |
| Income Tax Expense | 87.65 Million | 132.23 Million | 107.59 Million | 162.11 Million | 35.32 Million | 120.8 Million |
| Earnings before Tax | 598.97 Million | 1.07 Billion | 708.94 Million | 1.37 Billion | 229.46 Million | 1.18 Billion |
| Net Income | 419.39 Million | 728.65 Million | 601.35 Million | 1 Billion | 194.13 Million | 1.04 Billion |
| Earnings Per Share Basic | 0.26 | 0.46 | 0.38 | 0.65 | 0.13 | 0.68 |
| Earnings Per Share Diluted | 0.26 | 0.45 | 0.38 | 0.65 | 0.13 | 0.68 |
| Weighted Average Shares Outstanding | 1.6 Billion | 1.6 Billion | 1.6 Billion | 1.54 Billion | 1.53 Billion | 1.53 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.6 Billion | 1.6 Billion | 1.6 Billion | 1.54 Billion | 1.53 Billion | 1.53 Billion |
| Gross Margin | 0.83 | 0.88 | 0.89 | 0.86 | 0.80 | 0.80 |
| EBIT Margin | 0.23 | 0.32 | 0.32 | 0.40 | 0.25 | 1.57 |
| Profit Margin | 0.10 | 0.14 | 0.17 | 0.34 | 0.17 | 1.19 |
| EBITDA | 938.22 Million | 1.35 Billion | 865.89 Million | 1.5 Billion | 341.87 Million | 1.34 Billion |
| Earnings Before Tax Margin | 0.15 | 0.22 | 0.28 | 0.36 | 0.21 | 1.42 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 707.99 Million | 828.42 Million | 595.58 Million | 949.07 Million | 4.08 Billion | 990.37 Million |
| Cost of Revenue | 153.89 Million | 206.12 Million | 113.51 Million | 170.54 Million | 683.76 Million | 178.69 Million |
| Gross Profit | 554.1 Million | 622.3 Million | 482.06 Million | 778.52 Million | 3.39 Billion | 811.67 Million |
| Operating Expenses | 419.97 Million | 509.32 Million | 376.76 Million | 843.45 Million | 2.73 Billion | 616.44 Million |
| Selling, General and Administrative Expenses | 381.18 Million | 269.57 Million | 282.13 Million | 502.64 Million | - | 505.08 Million |
| Research and Development Expenses | 144.14 Million | 180.01 Million | 87.02 Million | 190.73 Million | - | 208.25 Million |
| Other Expenses | -105.35 Million | -59.73 Million | -7.6 Million | -150.06 Million | -165.07 Million | -1.05 Million |
| Cost and Expenses | 573.87 Million | 715.44 Million | 490.28 Million | 1.01 Billion | 3.41 Billion | 795.13 Million |
| Operating Income | 97.66 Million | 112.98 Million | 105.29 Million | -64.92 Million | 664.07 Million | 147.25 Million |
| Interest Expense | 2.51 Million | 1.77 Million | 3.38 Million | 2.19 Million | 5.94 Million | 1.03 Million |
| Income Tax Expense | 2.97 Million | 1.23 Million | 18.94 Million | 10.65 Million | 87.65 Million | 11.51 Million |
| Earnings before Tax | 96.09 Million | 220.52 Million | 57.16 Million | -176.06 Million | 598.59 Million | 146.19 Million |
| Net Income | 85.79 Million | 156.43 Million | 14.12 Million | -133.98 Million | 419.39 Million | 98.13 Million |
| Earnings Per Share Basic | 0.05 | 0.10 | 0.01 | -0.08 | - | 0.06 |
| Earnings Per Share Diluted | 0.05 | 0.10 | 0.01 | -0.08 | - | 0.06 |
| Weighted Average Shares Outstanding | 1.59 Billion | 1.59 Billion | 1.59 Billion | 1.59 Billion | 1.59 Billion | 1.59 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.59 Billion | 1.59 Billion | 1.59 Billion | 1.59 Billion | 1.59 Billion | 1.59 Billion |
| Gross Margin | 0.78 | 0.75 | 0.81 | 0.82 | 0.83 | 0.82 |
| EBIT Margin | 0.14 | 0.26 | 0.27 | 0.01 | - | 0.22 |
| Profit Margin | 0.12 | 0.19 | 0.02 | -0.14 | 0.10 | 0.10 |
| EBITDA | 98.61 Million | 213.54 Million | 162.95 Million | 13.33 Million | - | 213.1 Million |
| Earnings Before Tax Margin | 0.14 | 0.14 | 0.18 | -0.07 | 0.16 | 0.15 |
PALREDTEC
FONU
003022
GDHG
300813
002694